Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP examines the adequacy of Gossamer Bio, Inc.'s (NASDAQ: GOSS) risk disclosures in connection with a pending securities class...
-
PARSIPPANY, N.J., and TEL AVIV, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Eric Hughes, Teva's EVP of Global R&D...
-
OCTOPUS TITAN VCT PLC Annual report and financial statements for the year ended 31 December 2025 Octopus Titan VCT plc (‘Titan’ or the ‘Company’) is managed by Octopus AIF Management Limited (the...
-
LEADING EDGE MATERIALS ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS Vancouver, April 28, 2026 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM)...
-
OCTOPUS FUTURE GENERATIONS VCT PLC Annual report and financial statements for the year ended 31 December 2025 Octopus Future Generations VCT plc (‘Future Generations VCT’ or the ‘Company’) is...
-
EXOSENS ENREGISTRE UNE FORTE PERFORMANCE AU T1 2026, PORTÉE PAR L’ACCÉLÉRATION DE LA DYNAMIQUE EN IMAGERIE NUMÉRIQUE ET VISION NOCTURNE POUR LA DÉFENSE PARFAITEMENT EN LIGNE AVEC LES OBJECTIFS 2026 ...
-
EXOSENS DELIVERS STRONG Q1 2026 PERFORMANCE, WITH ACCELERATING DEFENSE MOMENTUMIN DIGITAL IMAGING AND NIGHT VISION FULLY ON TRACK TO DELIVER ON 2026 GUIDANCE HIGHLIGHTS Sustained revenue growth of...
-
Communiqué de Presse Résultats annuels 2025 CHIFFRE D’AFFAIRES : 1 736 M€ contre 1 865 M€ en 2024EBITDA AJUSTÉ : 145 M€ contre 109 M€ en 2024EBITA AJUSTÉ : 76 M€ contre 46 M€ en 2024FREE CASH-FLOW...
-
Press Release Results Full Year 2025 REVENUES: €1,736 MILLION vs 1,865 million in 2024ADJUSTED EBITDA: €145 MILLION vs €109 million in 20241ADJUSTED EBITA: €76 MILLION vs €46 million in 2024FCF...
-
Fidelity D&D Bancorp (NASDAQ: FDBC) announces Q2 2026 dividend of $0.43 per share, payable June 10, 2026 to shareholders of record May 20, 2026.